Elon Musk’s brain implant company Neuralink Corp. expects to put its chips in 20,000 people a year by 2031, generating at ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The Food and Drug Administration won’t sign off on Sarepta Therapeutics Inc. bringing its controversial gene therapy back to ...

Join Bloomberg’s Francine Lacqua, Dave Merritt and Allegra Stratton every Thursday as they uncover the best stories and speak ...

Communication has been a basic tool of central banking for decades, but it can be a tricky thing to get right. Merely ...

A First Nations group in British Columbia sent an open letter to Canadian Prime Minister Mark Carney urging him reject any ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Embattled Salvadoran immigrant Kilmar Abrego Garcia scored a pair of wins against the Trump administration as judges in two ...

A divided US Supreme Court let President Donald Trump temporarily remove three Democratic members of the Consumer Product ...

Mattel Inc. introduced a new forecast for 2025 sales and profit — two months after pulling its previous outlook over the ...

The eye-catching $2 trillion projection for the potential growth of the stablecoin market that was often cited during the ...

Tesla Inc.’s second-quarter earnings fell short of Wall Street’s estimates, as brand sentiment and rising competition take a ...